v environment. But the number of IPCs obtained at the end of the differentiation was low.
Hence, our results demonstrate that 3D differentiation generates functional IPCs in vitro unlike 2D differentiation. In the future we aim to improve the percentage of IPCs that we generate from the 3D differentiation. Our expectation is that these cells will be able to cure hyperglycemia in diabetic mice more rapidly compared to the 2D differentiated cells owing to their proven insulin production in the presence of a high glucose environment in vitro.
vi PUBLIC ABSTRACT Type 1 diabetes (T1D) is caused by the destruction of pancreatic β-cells. This process results in loss of the β-cell mass and reduced production of insulin. Lack of insulin, the key regulator of glucose, leads to elevated blood glucose levels, which can lead to the complications of diabetes such as blindness, cardiovascular disease, neuropathy and kidney failure. Our goal was to establish an alternative source of pancreatic β-cells. First, human skin cells were reprogrammed to generate induced pluripotent stem cells. These cells are very similar to embryonic stem cells in that they can be driven to generate any desired tissues such as pancreatic β-cells. We established a protocol that utilizes Matrigel to create the three dimensional (3D) environment which facilitates cell differentiation.
During the differentiation process, the cells were first differentiated to endodermal cells, which express CXCR4. Past this stage, the cells transitioned into pancreatic precursor cells, characterized by the expression of Pdx-1, a key pancreatic nuclear factor.
At the end of the differentiation procedure, the cells formed three characteristic types of clusters-tight clusters, cyst-like clusters that had a thick edge and cyst like clusters that contained compact clusters at the core. On characterization of the cells at the end of the differentiation process, the tight cell clusters were positive for insulin, C-peptide, Nkx6.1, and Nkx2.2. On glucose stimulation, the cells responded by secreting insulin. However, when compared to human pancreatic islets, the response to glucose stimulation by our cells was very low.
Thus, we have established a method for generating insulin producing cells from human skin cells. However, the protocol needs further improvement to enhance insulin secretion and we need to test our cells in vivo to determine whether they can correct glucose levels. There are two types of diabetes, namely, Type 1 diabetes (T1D) and Type 2 diabetes (T2D). T1D is an autoimmune disorder diagnosed in children and young adults.
Its prevalence in children earned it the name "juvenile diabetes". In T1D the body's own immune system destroys the pancreatic β-cells leading to underproduction of insulin.
Inadequate insulin production directly affects the glucose regulation in the body leading to hyperglycemia [2] [3] [4] . On the other hand, T2D is a result of the inability of the body to regulate glucose levels in the body due to insulin resistance. This occurs either due to disruption of the insulin receptors on the cells or due to glucose insensitivity of the insulin receptors. Insulin is thus not used to transport the glucose into the cells. The persistence of high glucose levels in spite of normal insulin production by the β-cells induces increased production of insulin initially. The functionality of the β-cells is impaired further on when the cells are unable to meet the demand for insulin and regulate hyperglycemia [5] .
Although T2D is more prevalent than T1D, due to its prevalence in children, its genetic nature, complications accompanying its occurrence and complications that ensue if treatments are not managed appropriately, T1D has been declared a chronic and potentially fatal disease. Insulin injections however have various disadvantages. They can lead to a sudden gain in weight, rashes and hematoma, dizziness, faster heartbeat, wheezing and shortness of breath. These side effects remove normalcy from the life of the patient. This has given way to efforts to transplant islet cells in order to replace the dysfunctional islets or induce islet cell proliferation to increase the number of existing islets.
Allo-transplantation of islets has met widespread success in reducing hyperglycemia and enabling the achievement of insulin independence to T1D patients [6] .
Allo-transplantation is defined as transplantation of cells or organs from a donor of the same species. The procedure of allo-transplantation of islets hence heavily relies on the availability of islet donors. The islets from the donors are purified from the pancreas by the use of a mixture of enzymes [6] . Each T1D patient typically receives 400,000 to 500,000 islets per infusion. The transplanted islets mature in vivo before they are fully functional [6] . The process of maturation includes adapting to the immune system and inducing the development of blood vessels to make the transplanted islets fully functional grafts. The most important aspect of islet functionality is detection of high glucose before the secretion of insulin. Hence, the patients who receive islets need to receive insulin injections to maintain normoglycemic levels while the transplanted islets mature in vivo [6] . Whole organ transplantation is used as an alternative technique to islet cell transplantation. The advantages of whole organ transplantation include longer functionality sustenance by the organ although surgery for whole organ transplantation is far more extensive than islet transplantation, where the islets are infused under the liver in a minimally invasive manner [6] .
Islet transplantation and whole organ pancreas transplantation is still an experimental technique and is not yet classified by the US FDA as a therapeutic technique [6] . The requirement to improve the technique is necessitated by the disadvantages of islet transplantation like the use of immunosuppressive drugs to prevent an immune reaction against the allo-graft, the inability of the technique to provide complete insulin independence to the patients and time taken by the transplanted cells to mature and become functional. Side effects of continued use of immune suppressive drugs includes increased cholesterol levels, high blood pressure, fatigue, anemia, decreased white blood cell counts, decreased kidney function and increased susceptibility to bacterial and viral infections. In 2011, 8000 organ donors were available, but only 1562 pancreases were recovered from donors. In spite of availability of the organs, the functionality needs to be carefully assessed before transplantation [6] . The quality assurance of donor organs eliminates many as they may not meet the criteria for transplantation or the islets might be destroyed while processing. The data on donor islet availability and their need clearly indicates the necessity to have a source of IPCs that is easily available and accessible.
Cell based therapies have emerged as possible treatments for T1D with the potential to be easily available and accessible. One strategy of treatment is inducing islet cell proliferation [7] [8] [9] . It was reported that a combination of EGF and gastrin increased the beta cell mass of isolated human adult islets in vitro [7] . Similarly in a different study, a xenograft of encapsulated sertoli cells induced beta cell neogenesis which reversed hyperglycemia in NOD mice. Several chemicals that are GSK-3β inhibitors, glucokinase activators, GPR119 agonists, L-type calcium channel activators and adenosine kinase inhibitors have been used to induce β-cell replication [10] .
With the discovery of stem cells, ES cells were extensively used to obtain IPCs [11] [12] [13] . The ES cells are isolated from the ICM of the blastocyst [14] [15] [16] . ES cells have the potential to differentiate into the three germ layers namely the endoderm, mesoderm and ectoderm and subsequently to any cell type required. The protocols being developed to differentiate ES cells to IPCs attempt to trace the path followed by the cells differentiating into the pancreatic β-cells during embryogenesis [17] . This is enabled by treating the cells with a cocktail of growth factors that are known to play a role in the development of pancreatic β-cells by suppressing the development of the hepatic and gastrointestinal cells [13, [18] [19] [20] [21] . The pancreas develops from the endoderm. After the formation of the primitive gut tube, cells from the anterior foregut differentiate into pancreatic progenitors [22] . The pancreatic progenitor cells, however, are precursors to the endocrine, acinar and ductal epithelial cells. Research has shown that the β-cells of the pancreas develop when the pancreatic endocrine progenitor cells come in contact with the dorsal aorta [23] .
Research on manipulation of the developmental pathways and signaling crosstalk by the use of growth factors has helped develop protocols for the differentiation of ES cells to pancreatic endocrine progenitor cells which on transplantation into diabetic mice successfully cured hyperglycemia [13, [18] [19] [20] [21] . However, current therapies with ES cells
have not yet established a protocol that provides mature functional IPCs in vitro [24] . The immune reaction after transplantation of the ES cells derived IPCs is another disadvantage to the use of ES derived IPCs as a therapy for T1D. differentiate into all three germ layers similar to the characteristics of ES cells [28, 29] .
This discovery created a new prospect of stem cell therapy for various diseases. First the stem cells are differentiated to endodermal cells. This involves the suppression of PI3K signaling and the subsequent upregulation of Nodal signaling [30, 31] . Nodal pathway plays an important role in formation of endodermal cells [32] . The Nodal ligands Figure 1 . The application of human iPS cells in the context of T1D. Fibroblasts obtained from T1D patient can be reprogrammed to form iPS cells. These stem cells can be banked and used subsequently, thus making them accessible and available when required. These iPS cells can be differentiated to IPCs. The IPCs generated can be transplanted back into the same T1D patient. Since the precursors to the IPCs are in fact the fibroblasts from the same person, this model has the potential to eliminate the immunological rejection after transplantation of the IPCs, thus providing long term insulin independence.
activate the ActrI/ActrII receptors, which leads to the phosphorylation of Smad 2/3 and their activation results in the upregulation of transcription of Lefty, Crypto. The transcription of Lefty and Crypto in turn upregulates the Nodal pathway [33] [34] [35] [36] [37] . This is a positive feed-back mechanism to sustain the Nodal signaling in order to bring about endodermal cell conversion. The endodermal cells then form the primitive gut tube. Spatial and temporal suppression/ upregulation of signaling pathways is important for organ specification in the gut tube. In order to form pancreatic cells, the suppression of Sonic Hedgehog (Shh) and BMP signaling in congruence with upregulation of Retinoic Acid signaling is required [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] . The subsequent suppression of Notch aids the formation of pancreatic endocrine cells [17, [48] [49] [50] [51] [52] [53] [54] [55] [56] . Further, the inhibition of Notch must be followed by PI3K upregulation and PARP inhibition to form IPCs and induce cell proliferation by inhibiting apoptosis [57] [58] [59] [60] . In a study, the development of β-cells was observed in the areas of the developing pancreas that were in contact with the endothelial cells of the dorsal aorta in mouse embryos [23] . Some reports suggest the exocrine tissue of the pancreas can be a source of the endocrine tissue [61, 62] . Recently, it was stated that a co-culture of endothelial cells, hepatic cells and stem cells was a successful system to generate IPCs [63] .
Generation of IPC from mouse ES cells was first reported in 2001. However, the insulin expressing cells produced by this protocol was later reported to be due to the uptake of exogenous insulin from the medium and not endogenous production of insulin [64] [65] [66] [67] .
Emphasis was thus given on elaborate study of stage-wise differentiation of pluripotent stem cells to IPCs. Research groups focused on the differentiation of stem cells to the endodermal stage to maximize the differentiation to pancreatic cell fate and later on methods to induce proliferation of progenitors at each stage in order to increase the size of progenitor pool and eventually increase efficiency of differentiation [68] [69] .
But most of the current protocols differentiate stem cells to pancreatic cells in a 2D culture system [70] . Upon transplantation under the kidney capsule, a small percentage of the 2D differentiated cells form IPCs in vivo and cure hyperglycemia over time [71] To alleviate the problem of organ shortage, our lab has pioneered the differentiation of human iPS cells to IPCs [76] . We found that ES cells engineered to constitutively express Pdx-1 and Rat Insulin Promoter (RIP) driven luciferase differentiated to IPCs and cured hyperglycemia when transplanted into diabetic mice [77] . Alternate protocols to generate IPCs in vitro in our lab included the use of the conventional 2D culture system of human iPS cell differentiation, in which the cells were exposed to a cocktail of growth factors that have been studied carefully for their ability to induce pancreatic differentiation.
The 2D iPS differentiation produced pancreatic endocrine cells that were bi-hormonal and the percentage of cells producing insulin was very low. Furthermore, the insulin secretory granules in the in vitro generated IPC did not have the same morphology as seen in β-cells when analyzed using transmission electron microscopy. On transplantation of these premature pancreatic cells in diabetic mice, reversal of hyperglycemia was observed only after 4 months. Additionally, the mice transplanted with in vitro generated IPCs died after a glucose challenge suggesting that the transplanted cells were not capable of handling high glucose levels. Our data thus indicated that the cells produced by 2D differentiation of iPS cells were not mature and functional IPCs. Changes in the protocol to make the process of differentiation more physiological than the previously used 2D differentiation and robust were necessary to generate functional IPCs in vitro. 
CHAPTER 2. MATERIALS AND METHODS

Human iPS cell lines and culture conditions
The four factor (4F) human iPS cells were used. The 4F iPS cells are derived by reprogramming human fibroblasts using four viral vectors. Reprogramming induces the expression of four transcription factors that revert them to stem cell state. The four transcription factors responsible to revert somatic cells to stem cells are Oct4, Sox2, Klf4 and c-Myc [27, 28] . The 4F iPS cells used for differentiation were generated by Dr E M Kim in Dr Zavazava's lab [78] . These cells were cultured on irradiated mouse embryonic fibroblasts (MEFs). The MEFs are required to maintain the pluripotency and self-renewal capacity of the iPS cells and are generally termed as feeder cells. The media used to culture these cells was supplemented with bFGF, which is known to maintain the pluripotency of the iPS cells by initiating the PI3K pathway [30, 31] . The iPS cells grow as colonies on the MEFs. Maintenance of these colonies is important to prevent differentiation to random cell types. The media was supplemented with a ROCK inhibitor to permit cell survival when dissociated from colonies during splitting and sorting of cells done to maintain their differentiation potential [79] .
When the cultures consist of spontaneously differentiated cells, pluripotent stem cells are purified by immunomagnetic bead sorting of CD326+ cells. CD326 is E-cadherin and the cells that express this cell surface marker are pluripotent and grow in colonies.
Hence, this process of sorting ensured that the cells used for differentiation were pluripotent and had not differentiated.
Establishing 3D cultures
Three dimensional (3D) cultures were established by coating plates with Matrigel diluted in media used for differentiation at a 1:1 ratio. This mixture of matrigel and media was added to the culture plates and incubated at 37 degrees Celsius for one hour. This initiated crosslinking of matrigel and coated the culture plates for differentiation.
Pluripotent human iPS cell colonies were seeded on the matrigel and then subjected to different differentiation media cocktails.
Differentiation of human iPS cells into IPCs
The process of differentiation of human iPS cells into IPCs consisted of first differentiating the iPS cells first to endodermal cells. After exposure to pancreatic growth factors, the endodermal cells were converted to pancreatic cells. The pancreatic cells were coaxed into endocrine cells that produced insulin in a high glucose environment. The process of differentiation was divided into five different stages. Figure 3 describes the growth factors used for cell fate specification at each stage of the differentiation process. In the first stage of the differentiation, the cells were subjected to 20ng/ml Wnt3A and 100ng/ml Activin A for one day followed by exposure only to 100ng/ml Activin A for two days. The presence of Wnt 3A for a day is known to induce the mesendodermal cell fate and the subsequent treatment with Activin A for two days produced endodermal cells. For the second stage of the differentiation cells were treated with 50ng/ml FGF-7 (KGF) for three days. The cells were then differentiated to a pancreatic cell lineage by using a cocktail of 2umol/ml Retinoic acid, 100ng/ml Noggin and 0.25umol/L Sant-1 for four days. Subsequently 1umol/L ALK5i and 50nmol/L TPB was used for three days to promote pancreatic endocrine cell fate [70] . The final and fifth stage was maturation of the pancreatic endocrine cells to IPCs. This was brought about by using nicotinamide and IGF-1 for about 6-10 days.
In contrast to the previously used 2D cultures, this protocol included the use of Wnt3a to ensure differentiation of the iPS cells to mesendodermal cells. In addition to this, the cells were differentiated when they were in a scaffold formed by polymerized matrigel, which provided the environment that enabled cell clustering. shows the images of cell clusters in matrigel with cells that expressed insulin.
These initial tests suggested that matrigel was a better polymer for 3D cultures than sodium alginate. The cells were not subjected to processes that could reduce their viability in the matrigel model and clustered a lot faster than that seen in sodium alginate. We concluded that for fragile cells like human induced pluripotent cells, reduced handling and culture time was beneficial and matrigel was thus chosen as the polymer to be used in differentiation. In the 2D cultures, on the other hand, cell proliferation was visible, but the cell organization was not distinguishable during differentiation. It was also noted that the cell density was very high at the end of the differentiation. While the presence of the Nkx6.1, Nkx 2.2, Glut 2, insulin and glucagon were visualized using confocal microscopy, the presence of insulin and glucagon producing cells were quantified using flow cytometry. 3.7 iPS-IPCs produced insulin when exposed to high glucose environment in vitro Pancreatic islets produce insulin when a high glucose environment is detected. High glucose stimulation is hence a proof of functionality of the pancreatic islets. In order to test the functionality of IPCs generated from iPS cells, the cells were maintained in high glucose medium. Insulin was quantified in the cell lysate of the IPCs after exposure to high glucose medium and compared with the lysate of the islets in similar experimental conditions. The insulin concentration was normalized to the total protein content in the cell lysate used. Figure 12 shows the relative levels of insulin production in 3D IPCs and human islets when maintained in high glucose media high glucose levels The insulin produced by the 3D differentiated cells and human islets in high glucose environment was quantified using ELISA. This indicated the difference in the insulin production between human islets and the IPCs generated by 3D differentiation.
Summary
Our experiments to establish a 3D culture system proved that matrigel served as the best polymer for this purpose.
When used for the differentiation of iPS cells, matrigel successfully established a 3D culture environment and maintained the cells through the process of differentiation. The 3D culture model also successfully differentiated the human iPS cells to fully functional IPCs. The IPCs were positive for the pancreatic transcription factors like Nkx6.1, Nkx2.2, Glut2, and for pancreatic hormones like insulin, c-peptide. They were also able to produce insulin when exposed to a high glucose environment. This proved that a more physiological system like the 3D culture model has the potential to generate functional IPCs.
CHAPTER 4. DISCUSSION
Matrigel is a protein mixture of secretions by mouse sarcoma cells [85] . It is a biopolymer that contains a mixture of many growth factors including bFGF, PDGF, EGF, IGF-1, NGF, TGF-β and tissue plasminogen activator [86, 87] . The biological constituents of matrigel help with cell survival and proliferation. The mixture of growth factors are known to help with maintenance of stem cell pluripotency when used in very diluted amounts and are known to promote stem cell proliferation and differentiation when used undiluted.
Matrigel polymerizes rapidly at room temperature and depolymerizes at 4 degrees Celsius. This property of matrigel was used to establish a cell culture system that supports a three dimensional culture. A 1:1 mixture of matrigel and cell culture medium (without serum) polymerized on cell culture dishes to form a three dimensional environment. The medium used was RPMI 1640, which provided, L-Glutamine, the sugars and the vitamins that are essential for the growth and proliferation of cells. The polymerization of matrigel with the medium ensured the formation of a scaffold with access to the growth factors and the essential nutrients from the medium. Incomplete RPMI was used to form the three dimensional culture systems to prevent the proteases in culture serum from degrading the protein mixture.
In the presence of the polymerized scaffold, the cells clustered and formed the more physiologically similar stem cell cultures than the conventional 2D cultures. The clustering of the cells was initiated naturally by the cells in an attempt to form colonies and support the maintenance of signaling crosstalk. We speculated that the physiologically similar structure thus formed will aid the process of differentiation.
To establish 3D cultures using the βTC3 cells, around 2. Hence, we decided to use Wnt3a for 24 hours before exposing the cells to Activin A only.
The process of differentiation is marked with the expression/downregulation of certain transcription factors. The differentiation of iPS cells is marked by loss of Nanog and Oct4 expression. Although the expression of Oct4 and Nanog was not analyzed for every differentiation, the cells were sorted for CD326 to ensure pluripotency.
The cells then begin to express CXCR4, marking their endodermal cell lineage.
Expression of CXCR4 was quantified to make sure the cells were differentiating. Emphasis was on attaining high percentage conversion to endodermal cells. Although only 40% conversion to endodermal cells was observed, reports of extended exposure to high concentration Activin A leading to loss of pancreatic differentiation capability led us to pursue methods to obtain a higher percentage conversion by manipulating the signaling pathways [89] . A recent paper has demonstrated that use of Nodal instead of Activin A produces mature endodermal cells at a much faster and efficient manner with greater capability to differentiate into pancreatic cells [33] . Future efforts will be aimed at generating higher percentage of endodermal cells so as to ensure better efficiency of differentiation into IPC.
The proof of pancreatic cell fate is the expression of Pdx-1. Since all pancreatic cells express Pdx-1, the distinguishing characteristic of IPCs from the other pancreatic cell fate is the expression of Nkx6.1. Nkx6.1 is a transcription factor required for β-cell maintenance and proliferation. Hence, its expression demonstrates differentiation to β-cells. The presence of Nkx2.2 is important for β-cell specification and differentiation.
While the presence of both Nkx6.1 and Nkx2.2 indicates the transcription machinery similar to that of the β-cells, proof of insulin production is required to demonstrate the generation of IPCs. Insulin production from the 3D differentiated IPCs was also compared to the islets after exposing them to a high glucose environment. The level of insulin detected in the cell lysate of the 3D differentiated IPCs was one fifth that of the islets. This This stain needs to be supplemented with a more specific assay like immunofluorescence analysis. Less numbers of clusters staining red in the dithizone assay indicated the possibility of low percentage of insulin producing cells obtained.
While it was indicated by multiple assays that the number of IPCs obtained was low, it was also indicative of definite presence of IPCs. The 3D differentiation protocol was able to produce IPCs in vitro unlike the 2D differentiation protocol. We speculate that the transplantation of these IPCs into diabetic mice will normalize the glucose levels much faster than the IPCs generated from 2D differentiation. With a faster reduction in glucose levels and reduced possibility of immune rejection after transplantation, this culture model has the potential to provide a long awaited cure for Type 1 Diabetes.
